We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Convey Health Solutions Holdings, Inc. (“Convey” or the “Company”) (NYSE: CNVY), in connection with the proposed acquisition of the Company by TPG Capital.  Under the terms of the merger agreement, the Company’s shareholders will receive $10.50 in cash for each share of Convey common stock owned.  The transaction is valued at approximately $1.1 billion.

Weiss Law is investigating whether (i) Convey’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $10.50 per-share merger consideration adequately compensates Convey’s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.  Notably, the merger consideration is below the $11.00 median price target set by analysts, and at least one analyst set a price target for the Company of $12 per share, $1.50 above the per-share merger consideration.